Author
Listed:
- Mengzhu Xue
(Laboratory of Systems Biology, Shanghai Advanced Research Institute, Chinese Academy of Sciences)
- Haiyue Liu
(Laboratory of Systems Biology, Shanghai Advanced Research Institute, Chinese Academy of Sciences)
- Liwen Zhang
(Shanghai Institute of Materia Medica, Chinese Academy of Sciences
College of Life Sciences, University of Chinese Academy of Sciences
School of Life Science and Technology, ShanghaiTech University)
- Hongyuan Chang
(Laboratory of Systems Biology, Shanghai Advanced Research Institute, Chinese Academy of Sciences
College of Life Sciences, University of Chinese Academy of Sciences)
- Yuwei Liu
(Laboratory of Systems Biology, Shanghai Advanced Research Institute, Chinese Academy of Sciences)
- Shaowei Du
(Laboratory of Systems Biology, Shanghai Advanced Research Institute, Chinese Academy of Sciences
School of Life Sciences, Shanghai University)
- Yingqun Yang
(Laboratory of Systems Biology, Shanghai Advanced Research Institute, Chinese Academy of Sciences
College of Life Sciences, University of Chinese Academy of Sciences
School of Life Science and Technology, ShanghaiTech University)
- Peng Wang
(Laboratory of Systems Biology, Shanghai Advanced Research Institute, Chinese Academy of Sciences
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
College of Life Sciences, University of Chinese Academy of Sciences
School of Life Science and Technology, ShanghaiTech University)
Abstract
Androgen-ablation therapies, which are the standard treatment for metastatic prostate cancer, invariably lead to acquired resistance. Hence, a systematic identification of additional drivers may provide useful insights into the development of effective therapies. Numerous microRNAs that are critical for metastasis are dysregulated in metastatic prostate cancer, but the underlying molecular mechanism is poorly understood. We perform an integrative analysis of transcription factor (TF) and microRNA expression profiles and computationally identify three master TFs, AR, HOXC6 and NKX2-2, which induce the aberrant metastatic microRNA expression in a mutually exclusive fashion. Experimental validations confirm that the three TFs co-dysregulate a large number of metastasis-associated microRNAs. Moreover, their overexpression substantially enhances cell motility and is consistently associated with a poor clinical outcome. Finally, the mutually exclusive overexpression between AR, HOXC6 and NKX2-2 is preserved across various tissues and cancers, suggesting that mutual exclusivity may represent an intrinsic characteristic of driver TFs during tumorigenesis.
Suggested Citation
Mengzhu Xue & Haiyue Liu & Liwen Zhang & Hongyuan Chang & Yuwei Liu & Shaowei Du & Yingqun Yang & Peng Wang, 2017.
"Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer,"
Nature Communications, Nature, vol. 8(1), pages 1-9, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14917
DOI: 10.1038/ncomms14917
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14917. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.